RIBASPHERE

Ribasphere Adverse Events Reported to the FDA Over Time

How are Ribasphere adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ribasphere, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ribasphere is flagged as the suspect drug causing the adverse event.

Most Common Ribasphere Adverse Events Reported to the FDA

What are the most common Ribasphere adverse events reported to the FDA?

Fatigue	461 (3.35%)
Nausea	341 (2.48%)
Anaemia	325 (2.36%)
White Blood Cell Count Decreased	323 (2.35%)
Weight Decreased	319 (2.32%)
Depression	277 (2.01%)
Asthenia	251 (1.83%)
Dizziness	225 (1.64%)
Vomiting	224 (1.63%)
Dyspnoea	208 (1.51%)
Insomnia	181 (1.32%)
	Show More
Platelet Count Decreased	171 (1.24%)
Headache	167 (1.21%)
Dehydration	164 (1.19%)
Alopecia	158 (1.15%)
Diarrhoea	158 (1.15%)
Pain	141 (1.03%)
Pyrexia	125 (.91%)
Decreased Appetite	117 (.85%)
Anxiety	116 (.84%)
Haemoglobin Decreased	111 (.81%)
Rash	111 (.81%)
Loss Of Consciousness	107 (.78%)
Condition Aggravated	104 (.76%)
Red Blood Cell Count Decreased	103 (.75%)
Arthralgia	102 (.74%)
Cough	100 (.73%)
Chest Pain	97 (.71%)
Anorexia	92 (.67%)
Back Pain	87 (.63%)
Influenza Like Illness	84 (.61%)
Suicidal Ideation	82 (.6%)
Fall	80 (.58%)
Tremor	77 (.56%)
Pneumonia	76 (.55%)
Vision Blurred	76 (.55%)
Pruritus	74 (.54%)
Malaise	71 (.52%)
Chills	68 (.49%)
Irritability	66 (.48%)
Myalgia	66 (.48%)
Feeling Abnormal	65 (.47%)
Abdominal Pain	64 (.47%)
Anger	61 (.44%)
Abdominal Pain Upper	59 (.43%)
Constipation	59 (.43%)
Memory Impairment	59 (.43%)
Blood Glucose Increased	58 (.42%)
Disturbance In Attention	58 (.42%)
Dry Skin	58 (.42%)
Confusional State	54 (.39%)
Hyperhidrosis	53 (.39%)
Hypertension	53 (.39%)
Muscle Spasms	52 (.38%)
Blood Potassium Decreased	51 (.37%)
Neutropenia	51 (.37%)
Dysgeusia	46 (.33%)
Epistaxis	46 (.33%)
Injection Site Erythema	46 (.33%)
Dry Mouth	45 (.33%)
Crying	44 (.32%)
Hypoaesthesia	39 (.28%)
Pain In Extremity	38 (.28%)
Sinusitis	38 (.28%)
Convulsion	37 (.27%)
Drug Exposure During Pregnancy	37 (.27%)
Somnolence	37 (.27%)
Hypotension	35 (.25%)
Pallor	35 (.25%)
Bronchitis	34 (.25%)
Drug Ineffective	34 (.25%)
Balance Disorder	33 (.24%)
Chest Discomfort	33 (.24%)
Mood Swings	33 (.24%)
Hypothyroidism	32 (.23%)
Oropharyngeal Pain	32 (.23%)
Palpitations	32 (.23%)
Amnesia	30 (.22%)
Drug Dose Omission	30 (.22%)
Haematocrit Decreased	30 (.22%)
Migraine	30 (.22%)
Contusion	29 (.21%)
Rash Pruritic	29 (.21%)
Treatment Noncompliance	29 (.21%)
Dyspnoea Exertional	28 (.2%)
Haemolytic Anaemia	28 (.2%)
Hypersomnia	28 (.2%)
Muscular Weakness	28 (.2%)
Nasopharyngitis	28 (.2%)
Pancytopenia	28 (.2%)
Abdominal Distension	27 (.2%)
Disorientation	27 (.2%)
Dysphagia	27 (.2%)
Head Injury	27 (.2%)
Oedema Peripheral	27 (.2%)
Thirst	26 (.19%)
Dysuria	25 (.18%)
Ear Infection	25 (.18%)
Blood Pressure Increased	24 (.17%)
Burning Sensation	24 (.17%)
Haemorrhage	24 (.17%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ribasphere, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ribasphere is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ribasphere

What are the most common Ribasphere adverse events reported to the FDA?

Hematology Investigations	874 (6.35%)
Gastrointestinal Signs	820 (5.96%)
Neurological	747 (5.43%)
Respiratory	511 (3.72%)
Epidermal And Dermal Conditions	443 (3.22%)
Infections - Pathogen Unspecified	428 (3.11%)
Anemias Nonhemolytic And Marrow Dep...	369 (2.68%)
Physical Examination Topics	353 (2.57%)
Depressed Mood Disorders	317 (2.3%)
Gastrointestinal Motility And Defec...	256 (1.86%)
Skin Appendage Conditions	250 (1.82%)
	Show More
Appetite And General Nutritional	244 (1.77%)
Electrolyte And Fluid Balance Condi...	228 (1.66%)
Anxiety Disorders	206 (1.5%)
Headaches	203 (1.48%)
Musculoskeletal And Connective Tiss...	202 (1.47%)
Sleep Disorders	201 (1.46%)
Injuries	186 (1.35%)
Administration Site Reactions	181 (1.32%)
Muscle	168 (1.22%)
Mental Impairment	157 (1.14%)
Joint	148 (1.08%)
Mood Disorders	146 (1.06%)
Body Temperature Conditions	125 (.91%)
Vision	110 (.8%)
Movement Disorders	107 (.78%)
Suicidal And Self-injurious Behavio...	103 (.75%)
Therapeutic And Nontherapeutic Effe...	102 (.74%)
Water, Electrolyte And Mineral	99 (.72%)
Cardiac And Vascular Investigations	95 (.69%)
Deliria	93 (.68%)
Lifestyle Issues	90 (.65%)
Urinary Tract Signs	90 (.65%)
Gastrointestinal Hemorrhages	89 (.65%)
Metabolic, Nutritional And Blood Ga...	89 (.65%)
Oral Soft Tissue Conditions	84 (.61%)
Disturbances In Thinking	83 (.6%)
Hepatobiliary	82 (.6%)
Medication Errors	80 (.58%)
Upper Respiratory Tract Disorders	74 (.54%)
Dental And Gingival Conditions	72 (.52%)
Viral Infectious	70 (.51%)
Chemical Injury And Poisoning	68 (.49%)
Hepatic And Hepatobiliary	66 (.48%)
White Blood Cell	66 (.48%)
Personality Disorders	63 (.46%)
Thyroid Gland	63 (.46%)
Bacterial Infectious	62 (.45%)
Procedural And Device Related Injur...	62 (.45%)
Seizures	57 (.41%)
Vascular	56 (.41%)
Vascular Hypertensive	53 (.39%)
Cardiac Disorder Signs	51 (.37%)
Tongue Conditions	51 (.37%)
Glucose Metabolism Disorders	49 (.36%)
Salivary Gland Conditions	47 (.34%)
Eye	44 (.32%)
Central Nervous System Vascular	43 (.31%)
Decreased And Nonspecific Blood Pre...	42 (.31%)
Psychiatric	42 (.31%)
Renal Disorders	42 (.31%)
Cardiac Arrhythmias	41 (.3%)
Lower Respiratory Tract Disorders	41 (.3%)
Coronary Artery	37 (.27%)
Renal And Urinary Tract Investigati...	37 (.27%)
Fungal Infectious	36 (.26%)
Gastrointestinal Conditions	33 (.24%)
Bronchial Disorders	32 (.23%)
Hemolyses And Related Conditions	32 (.23%)
Arteriosclerosis, Stenosis, Vascula...	31 (.23%)
Bone And Joint Injuries	31 (.23%)
Gallbladder	31 (.23%)
Gastrointestinal Vascular Condition...	31 (.23%)
Vascular Hemorrhagic	31 (.23%)
Sleep Disturbances	30 (.22%)
Allergic Conditions	28 (.2%)
Aural	28 (.2%)
Cranial Nerve Disorders	27 (.2%)
Gastrointestinal Ulceration And Per...	27 (.2%)
Musculoskeletal And Connective Tiss...	27 (.2%)
Skin And Subcutaneous Tissue	26 (.19%)
Tissue	26 (.19%)
Bone Disorders	24 (.17%)
Inner Ear And Viiith Cranial Nerve	23 (.17%)
Microbiology And Serology	22 (.16%)
Pleural	21 (.15%)
Angiedema And Urticaria	20 (.15%)
Cardiac Valve	20 (.15%)
Platelet	20 (.15%)
Embolism And Thrombosis	19 (.14%)
Manic And Bipolar Mood Disorders	19 (.14%)
Neonatal And Perinatal Conditions	19 (.14%)
Pregnancy, Labour, Delivery And Pos...	19 (.14%)
Retina, Choroid And Vitreous Hemorr...	19 (.14%)
Skin Vascular Abnormalities	19 (.14%)
Investigations, Imaging And Histopa...	18 (.13%)
Schizophrenia And Other Psychotic	18 (.13%)
Peripheral Neuropathies	17 (.12%)
Communication Disorders	16 (.12%)
Family Issues	16 (.12%)
Spleen, Lymphatic And Reticulendoth...	16 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ribasphere, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ribasphere is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.